Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 124,838 | 73,683 | 35,740 | 27,733 | 13,487 |
| Depreciation Amortization | 93,565 | 59,859 | 29,581 | 120,090 | 88,994 |
| Income taxes - deferred | 1,201 | -3,205 | -940 | 1,369 | -720 |
| Accounts receivable | -18,126 | -2,390 | 488 | 10,999 | 10,992 |
| Other Working Capital | 70,051 | 48,452 | 20,481 | 83,470 | 66,095 |
| Other Operating Activity | -11,852 | -14,335 | -9,561 | 33,355 | 19,356 |
| Operating Cash Flow | $259,677 | $162,064 | $75,789 | $277,016 | $198,204 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -84 | -3,477 | -2,529 | -24,478 | -26,794 |
| PPE Investments | -744,094 | -225,346 | -142,864 | -118,153 | 26,455 |
| Other Investing Activity | 1,252 | 1,252 | 1,285 | 108,663 | 16,943 |
| Investing Cash Flow | $-742,926 | $-227,571 | $-144,108 | $-33,968 | $16,604 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,221,888 | 260,000 | 141,000 | 1,186,537 | 1,025,527 |
| Debt Repayment | -707,890 | -183,743 | -59,887 | -1,349,918 | -911,946 |
| Common Stock Issued | 1,764 | 1,697 | 1,499 | 4,163 | 3,397 |
| Common Stock Repurchased | -12,788 | -12,788 | -12,788 | -7,946 | N/A |
| Dividend Paid | -22,217 | -14,805 | -7,399 | -17,706 | -11,048 |
| Other Financing Activity | -1,584 | 0 | 0 | -65,012 | -11,515 |
| Financing Cash Flow | $479,173 | $50,361 | $62,425 | $-249,882 | $94,415 |
| Exchange Rate Effect | -114 | -127 | -8 | 97 | -15 |
| Beginning Cash Position | 66,502 | 66,502 | 66,502 | 73,239 | 73,239 |
| End Cash Position | 62,312 | 51,229 | 60,600 | 66,502 | 382,447 |
| Net Cash Flow | $-4,190 | $-15,273 | $-5,902 | $-6,737 | $309,208 |
| Free Cash Flow | |||||
| Operating Cash Flow | 259,677 | 162,064 | 75,789 | 277,016 | 198,204 |
| Capital Expenditure | -821,900 | -276,726 | -171,647 | -219,450 | -49,223 |
| Free Cash Flow | -562,223 | -114,662 | -95,858 | 57,566 | 148,981 |